Nitrofuran compounds for the treatment of cancer and angiogenesis
US9220714B2 · kind B2 · utility
2Cited by
1References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 17, 2013 |
| Grant date | Dec 29, 2015 |
| Priority date | — |
| Expiry date | May 17, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to the synthesis and use of nitrofuran compounds, especially Nifurtimox, as medicaments to treat cancer, especially neuroblastoma, and to inhibit angiogenesis. The invention also provides compositions, unit dosage forms, and kits comprising the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.